Dr Lorraine Work
Place of work / study:
University of Glasgow
Area of research:
Vascular cognitive impairment, small vessel disease and ischaemic stroke
How is your work funded:
My research is currently supported by the Chief Scientist Office and through PhD studentships awarded by the Cunningham Trust and the British Heart Foundation. I also have small grant support through the Alzheimer’s Research UK Scotland Network as well as support for Vacation Student projects from the Wellcome Trust.
Tell us a little about yourself:
I graduated from the University of Strathclyde with a BSc (Hons) in Immunology & Pharmacology (1995) and went on to study for my PhD (1999). I joined the Division of Cardiovascular and Medical Science, University of Glasgow in 2000 as a post-doctoral researcher. I was awarded a BHF Intermediate Research Fellowship in 2006 to study a combination of pharmacological and gene-based therapies in stroke. In 2007, I was appointed lecturer through the BBSRC Capacity Building awards in Integrative Mammalian Biology (IMB) and so central to my research is the translation of knowledge gained from single molecules back to the whole organism, including in vivo studies. In 2015 I was promoted to Senior Lecturer and to Reader in 2019. I’m happily married to a very patient and understanding guy (needed when you’re married to an academic!) with 2 wonderful kids (one at High School, one at Primary School) and I’ve worked part-time (0.9FTE) since 2010 to try to find a work:life balance that works for all of us.
Tell us a fun fact about yourself:
I was born and brought up in Orkney, a small group of islands off the North-East coast of Scotland. I am very proud of my island heritage and to be Orcadian!
Why did you choose to work in dementia?
Stroke is one of the major risk factors for the subsequent development of dementia. It is one of the most feared complications in stroke survivors and hence, is an area that my research has naturally moved towards. To better understand why stroke may lead to dementia has to be a research priority as if we can reduce stroke burden we can potentially impact positively on the incidence of dementia.